Literature DB >> 29540347

RUNX1 mutations in pediatric acute myeloid leukemia are associated with distinct genetic features and an inferior prognosis.

Genki Yamato1,2,3, Norio Shiba3,4, Kenichi Yoshida5, Yusuke Hara2,3, Yuichi Shiraishi6, Kentaro Ohki7, Jun Okubo1, Myoung-Ja Park1, Manabu Sotomatsu1, Hirokazu Arakawa2, Nobutaka Kiyokawa7, Daisuke Tomizawa8, Souichi Adachi9, Takashi Taga10, Keizo Horibe3, Satoru Miyano6,11, Seishi Ogawa5,12, Yasuhide Hayashi1,3,13.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29540347     DOI： 10.1182/blood-2017-11-814442

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.

Authors:  Norio Shiba; Kenichi Yoshida; Yusuke Hara; Genki Yamato; Yuichi Shiraishi; Hidemasa Matsuo; Yusuke Okuno; Kenichi Chiba; Hiroko Tanaka; Taeko Kaburagi; Masanobu Takeuchi; Kentaro Ohki; Masashi Sanada; Jun Okubo; Daisuke Tomizawa; Tomohiko Taki; Akira Shimada; Manabu Sotomatsu; Keizo Horibe; Takashi Taga; Souichi Adachi; Akio Tawa; Satoru Miyano; Seishi Ogawa; Yasuhide Hayashi
Journal:  Blood Adv       Date:  2019-10-22

Review 2.  Beyond Pathogenic RUNX1 Germline Variants: The Spectrum of Somatic Alterations in RUNX1-Familial Platelet Disorder with Predisposition to Hematologic Malignancies.

Authors:  Alisa Förster; Melanie Decker; Brigitte Schlegelberger; Tim Ripperger
Journal:  Cancers (Basel)       Date:  2022-07-14       Impact factor: 6.575

3.  Elevated RUNX1 is a prognostic biomarker for human head and neck squamous cell carcinoma.

Authors:  Xiaodong Feng; Zhiwei Zheng; Yi Wang; Guanghui Song; Lu Wang; Zhijun Zhang; Jinxia Zhao; Qing Wang; Limin Lun
Journal:  Exp Biol Med (Maywood)       Date:  2020-11-26

4.  RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses.

Authors:  Matti Kankainen; Satu Mustjoki; Shady Adnan Awad; Olli Dufva; Aleksandr Ianevski; Bishwa Ghimire; Jan Koski; Pilvi Maliniemi; Daniel Thomson; Andreas Schreiber; Caroline A Heckman; Perttu Koskenvesa; Matti Korhonen; Kimmo Porkka; Susan Branford; Tero Aittokallio
Journal:  Leukemia       Date:  2020-08-11       Impact factor: 11.528

5.  Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemia.

Authors:  Taeko Kaburagi; Genki Yamato; Norio Shiba; Kenichi Yoshida; Yusuke Hara; Ken Tabuchi; Yuichi Shiraishi; Kentaro Ohki; Manabu Sotomatsu; Hirokazu Arakawa; Hidemasa Matsuo; Akira Shimada; Tomohiko Taki; Nobutaka Kiyokawa; Daisuke Tomizawa; Keizo Horibe; Satoru Miyano; Takashi Taga; Souichi Adachi; Seishi Ogawa; Yasuhide Hayashi
Journal:  Haematologica       Date:  2022-03-01       Impact factor: 9.941
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.